Filing Details

Accession Number:
0001140361-16-080481
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-21 19:52:27
Reporting Period:
2016-09-19
Filing Date:
2016-09-21
Accepted Time:
2016-09-21 19:52:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1213041 A Elizabeth Grammer C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Svp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-19 5,000 $1.08 6,859 No 4 M Direct
Common Stock Disposition 2016-09-19 6,859 $11.21 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2016-09-19 2,500 $0.00 2,500 $1.08
Common Stock Stock Option (Right to Buy) Disposition 2016-09-19 2,500 $0.00 2,500 $1.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-10-26 No 4 M Direct
2,500 2021-04-15 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 19, 2016.
  2. Includes an aggregate of 1,859 shares acquired under the Issuer's Employee Stock Purchase Plan on February 29, 2016.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.04 to $11.26, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  4. The option is fully vested and exercisable.